Jacobo Abadi, MD
Dr. Abadi is an Attending in the Division of Pediatric Infectious Diseases. Dr. Abadi is a committee member of the New York State HIV Clinical Guidelines Program. Dr. Abadi is board-certified in Pediatric Infectious Diseases and he is an Associate Professor of Clinical Pediatrics at the Albert Einstein College of Medicine.
Luis Razetti School of Medicine, Central University Venezuela
- Internship and Residency: Montefiore Medical Center
- Infectious Disease Fellowship: Montefiore Medical Center
- Sharp ER, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, et al: Nixon DF. Association of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected children. PLoS One 2012;7(1):e29154.
- Sharp ER, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia AA, Rosenberg MG, et al: Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents. PLoS One 2011;6(7):e21135.
- Phillips UK, Rosenberg MG, Dobroszycki Wiznia AA, Abadi J. et al: Pregnancy in women with perinatally acquired HIV-infection: outcomes and challenges. AIDS Care 2011 Sep;23(9):1076-82.
- Ballan WM, Wiznia AA, Abadi J, Fennelly GJ, Rosenberg MG, et al: Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. J Immunol 2007 Sep 1;179(5):3362-70.
- Toussi SS, Abadi J, Rosenberg M, et al: Prevalence of hepatitis B and C virus infections in children infected with HIV. Clin Infect Dis 2007;45:795-8.
- Rosenberg M, Abadi J, Dobroszycki J, Wiznia A. Progress and Challenges in Antiretroviral Therapy of HIV-infected Children. Current Infectious Disease Reports, 2006 8:324-33.
- Ballan WM, Vu BA, Abadi J, et al: Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. J Immunol 2007;179:3362-70.
- Abadi J, Sprecher E, Rosenberg MG, et al: Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children. J Acquir Immune Defic Syndr 2006r;41:298-303.
- Dehority W, Abadi J, Wiznia A, Viani RM. Use of integrase inhibitors in hiv-infected children and adolescents. Drugs. 2015 Sep;75(13):1483-97.